|
Mucormycosis and COVID-19: A systematic review
|
Mojtaba Sepandi    , Yousef Alimohamadi * , Kolsoom Alimohamadi , Maedeh Arshadi , Aghil Sharifzadeh |
| Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran , y.alimohamadi67@gmail.com |
|
|
Abstract: (402 Views) |
Background and aims: Identifying factors that contribute to the progression of COVID-19 in patients is crucial for preventing fatalities. Mucormycosis is one such influential factor. Hence, this study aimed to conduct a systematic review on the correlation between black fungus infection and COVID19.
Methods: This systematic review followed the PRISMA protocol and utilized international databases.
Results: A total of 161 cases were documented among 7495 COVID-19 patients. The majority of cases were reported in India. Among the case reports, 16 (76%) were male and six (24%) were female. Diabetes mellitus was prevalent in 56% of cases, with hypertension being the second most common comorbidity. Rhinocerebral mucormycosis emerged as the most prevalent clinical form of the disease.
Conclusion: Timely identification of mucormycosis cases, monitoring of hyperglycemia, appropriate use of antibiotics, and corticosteroids can help curb the rising incidence of this fungal infection.
|
|
| Keywords: Mucormycosis, COVID-19, Systematic Review |
|
|
Full-Text [PDF 586 kb]
(202 Downloads)
|
Type of Study: Review |
Subject:
Disaster Medicine
Received: 2022/07/8 | Revised: 2024/06/1 | Accepted: 2023/08/22 | Published: 2024/03/7
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
